Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
CartilaGen
company
About
CartilaGen is a startup focusing on developing drug-eluting bioactive materials to treat articular cartilage damage and osteoarthritis.
- 1 - 10
Highlights
Details
- Last Funding Type
- Grant
- Industries
- Biotechnology,Health Care
- Founded date
- Sep 8, 2015
- Number Of Employee
- 1 - 10
- Operating Status
- Active
CartilaGen is a biotechnology startup focusing on developing drug-eluting bioactive materials to treat articular cartilage damage and osteoarthritis.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
—
CartilaGen has raised a total of
—
in funding over 2 rounds. Their latest funding was raised on
Feb 23, 2021 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Feb 23, 2021 | Grant | — | 1 |
Iowa G2M Accelerator
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
CartilaGen is funded by 1 investors.
Iowa G2M Accelerator
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Iowa G2M Accelerator
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
